Director, Value Evidence Strategy, Nephrology

Reporting to the Senior Director (SD) of Nephrology/Immunology, Value Evidence Strategy, Director - Value Evidence Strategy, Rare Disease(s), will be responsible for leading the strategy development and implementation of health economics and outcomes research (HEOR) studies and value evidence generation for health technology assessment (HTA) needs for assets in the rare disease area. This person will have to lead a cross-functional team, Value Evidence Sub-Committee, to ensure Integrated Value Evidence Plans are developed and executed to address evidence needs of key stakeholders including payers, HCPs, policy and decision makers, and patients/caregivers.

The Director, Value Evidence Strategy, role is responsible for assessing the value evidence needs for HTA purposes for the assigned Rare Disease assets and its indications and the development and implementation of the Integrated Value Evidence Plan leading a Value Evidence Sub-Committee for that relevant product and indications globally. This position reports to the Senior Director, Value Evidence Strategy.

The role comprises the following responsibilities:

• Responsibility for leading and coordinating the health technology and value evidence input into clinical development programs.
• Serves on product development committee and support the SD for tasks related to internal and/or alliance governance committees.
• Lead Value Evidence Sub-Committee.
• Lead the development of Integrated Value Evidence Plan (IVEP).
• Develops the global value evidence strategy taking into account payer (including health technology assessment agencies), provider, patient, and policy maker evidence needs.
• Assess the HTA needs for the assigned product and disease area in general and tracking the methodological needs.
• Responsibility for completion of all global deliverables for the assigned product/ indication to support HTA and reimbursement submissions, including economic models, real world evidence, evidence synthesis & meta-analysis, global HTA statistical analysis plan, and global value dossier, and AMCP-format dossier.
• Coordinates and provides scientific support for HTA submissions outside the US, with subsidiaries. Leads Company responses to HTA evaluations in the US (e.g., ICER).
• Develops and generates post-approval real world evidence on our company's product in collaboration with external researchers and experts in the field.
• Responsibility for developing a comprehensive publication and communication plan including presentation and publication of key value evidence at scientific conferences and peer reviewed journals.

Qualifications/ Required

Knowledge/ Experience and Skills:

• Minimum 6 years for PhD/MD/Pharm D or 12 years for Master's degree of relevant pharmaceutical company or payer experience in the area of access, outcomes research, health economics, observational studies, Health Technology Assessment or related area.
• Late stage drug development and launch experience
• Experience with evidence generation in rare diseases
• PhD or Master's in health economics, outcomes research, epidemiology, health services research, health policy, pharmaceutical administration or related field OR MD or Pharm D.

Disclaimer

This job description is intended to describe the general nature and level of the work being performed by the people assigned to this position. It is not intended to include every job duty and responsibility specific to the position. Otsuka reserves the right to amend and change responsibilities to meet business and organizational needs as necessary.

Equal Opportunity Employer

Otsuka is an equal opportunity employer. All qualified applicants are encouraged to apply and will receive consideration for employment without regard to their protected veteran or disabled status, or any protected status.

Competencies
Accountability for Results - Stay focused on key strategic objectives, be accountable for high standards of performance, and take an active role in leading change.
Strategic Thinking & Problem Solving - Make decisions considering the long-term impact to customers, patients, employees, and the business.
Patient & Customer Centricity - Maintain an ongoing focus on the needs of our customers and/or key stakeholders.
Impactful Communication - Communicate with logic, clarity, and respect. Influence at all levels to achieve the best results for Otsuka.
Respectful Collaboration - Seek and value others’ perspectives and strive for diverse partnerships to enhance work toward common goals.
Empowered Development - Play an active role in professional devel